BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3718209)

  • 1. Effect of prolonged intra-arterial prostaglandin E1 infusion on canine arterial graft patency.
    Cronenwett JL; Shapiro DM; Luce JL
    Arch Surg; 1986 Jul; 121(7):760-4. PubMed ID: 3718209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial 9-beta-methyl carbacyclin improves canine polytetrafluoroethylene graft patency.
    Dacey LJ; Hees PS; Cronenwett JL
    J Vasc Surg; 1988 Jul; 8(1):21-7. PubMed ID: 3133494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG; Hobson RW; Barbalinardo JP; Kerr JC
    Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin E1 on blood flow in normal and ischemic canine hindlimbs.
    Pasch AR; Ricotta JJ; Burke AR; O'Mara RE; DeWeese JA; Wilson G
    Surgery; 1984 Jun; 95(6):724-9. PubMed ID: 6539509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of stellate ganglion block with intravascular infusion of prostaglandin E1 on brachial artery blood flow in dogs.
    Okuda Y; Kitajima T
    Anesth Analg; 1997 Jun; 84(6):1329-32. PubMed ID: 9174315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of combined sympathetic block and intravascular infusion of prostaglandin E1 on brachial arterial blood flow in dogs.
    Okuda Y; Kitajima T
    Anesth Analg; 1999 Dec; 89(6):1514-6. PubMed ID: 10589639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T; Eckstein H; Weiss C; Diehm C
    Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgraft infusion of heparin to prevent early thrombosis of expanded PTFE grafts in canine femoral veins.
    Chen C; Hughes JD; Mattar SG; Hanson SR; Lumsden AB
    Ann Vasc Surg; 1996 Mar; 10(2):147-55. PubMed ID: 8733867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of groin incision, duration of ischemia, and prostaglandin E1 on ischemia-reperfusion injury of the lower limb.
    Frässdorf J; Luther B; Müllenheim J; Otto F; Preckel B; Schlack W; Thämer V
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):187-95. PubMed ID: 16616658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
    Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
    Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of adjunctive arteriovenous fistula on prosthetic graft patency: a controlled study in a canine model.
    Calligaro KD; Ascer E; Torres M; Veith FJ
    J Cardiovasc Surg (Torino); 1990; 31(5):646-50. PubMed ID: 2229165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental femoral vein reconstruction with expanded polytetrafluoroethylene grafts seeded with endothelial cells.
    Li JM; Menconi MJ; Wheeler HB; Rohrer MJ; Anderson FA; Cutler BS
    Cardiovasc Surg; 1993 Aug; 1(4):362-8. PubMed ID: 8076060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
    Schellong SM; Burchert W; Böger RM; Creutzig A; Hundeshagen H; Alexander K
    Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the patency of small-caliber prostheses: Observations in a suitable canine model.
    Jones DN; Rutherford RB; Ikezawa T; Nishikimi N; Ishibashi H; Whitehill TA
    J Vasc Surg; 1991 Oct; 14(4):441-8; discussion 448-51. PubMed ID: 1920641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
    Weiss T; Fischer D; Hausmann D; Weiss C
    Prostaglandins Leukot Essent Fatty Acids; 2002 Nov; 67(5):277-81. PubMed ID: 12445486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of external reinforcement on the patency of infrainguinal polytetrafluoroethylene arterial grafts.
    Sullivan TM; Dunn MM
    J Am Coll Surg; 1996 Mar; 182(3):211-4. PubMed ID: 8603239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet deposition on polytetrafluoroethylene grafts by antiplatelet agents.
    Kon ND; Hansen KJ; Martin MB; Meredith JW; Meredith JH; Cordell AR
    Surgery; 1984 Nov; 96(5):870-3. PubMed ID: 6387989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
    Freeman MB; Sicard GA; Valentin LI; Neuberger S; Mangino MJ; Anderson CB
    J Vasc Surg; 1988 Apr; 7(4):554-61. PubMed ID: 3127601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.